A Review of Fatty Acid Biosynthesis Enzyme Inhibitors as Promising Antimicrobial Drugs
Pharmaceuticals · 10.03.2023 · 16 (3) · 425
DOI: 10.3390/ph16030425 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 10.03.2023. Verfasst von Laurie Bibens und 3 weiteren Autor:innen. Beteiligte Einrichtung: Agents Infectieux, Résistance et Chimiothérapie, UR 4294, Université de Picardie-Jules-Verne, UFR de Pharmacie, 1 Rue des Louvels, CEDEX 1, F-80037 A…. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Région Hauts de France, Agence de l'Innovation de Défense, AID.
Abstract (Originalsprache)
Resistance to antimicrobial drugs is currently a serious threat to human health. Consequently, we are facing an urgent need for new antimicrobial drugs acting with original modes of action. The ubiquitous and widely conserved microbial fatty acid biosynthesis pathway, called FAS-II system, represents a potential target to tackle antimicrobial resistance. This pathway has been extensively studied, and eleven proteins have been described. FabI (or InhA, its homologue in mycobacteria) was considered as a prime target by many teams and is currently the only enzyme with commercial inhibitor drugs: triclosan and isoniazid. Furthermore, afabicin and CG400549, two promising compounds which also target FabI, are in clinical assays to treat Staphylococcus aureus. However, most of the other enzymes are still underexploited targets. This review, after presenting the FAS-II system and its enzymes in Escherichia coli, highlights the reported inhibitors of the system. Their biological activities, main interactions formed with their targets and structure–activity relationships are presented as far as possible.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Agents Infectieux, Résistance et Chimiothérapie, UR 4294, Université de Picardie-Jules-Verne, UFR de Pharmacie, 1 Rue des Louvels, CEDEX 1, F-80037 Amiens, France.
ORCID-Profile: Laurie Bibens, Pascal Sonnet
Förderung
- Région Hauts de France
- Agence de l'Innovation de Défense
- AID
- Hauts-de-France region
Zitieren
APA
Bibens, L., Becker, J. P., Dassonville-Klimpt, A., & Sonnet, P. (2023). A Review of Fatty Acid Biosynthesis Enzyme Inhibitors as Promising Antimicrobial Drugs. Pharmaceuticals, 16(3), 425. https://doi.org/10.3390/ph16030425
Vancouver
Bibens L, Becker JP, Dassonville-Klimpt A, Sonnet P. A Review of Fatty Acid Biosynthesis Enzyme Inhibitors as Promising Antimicrobial Drugs. Pharmaceuticals. 2023;16(3):425. doi:10.3390/ph16030425
BibTeX
@article{Bibens2023,
author = {Bibens, Laurie and Becker, Jean-Paul and Dassonville-Klimpt, Alexandra and Sonnet, Pascal},
title = {A Review of Fatty Acid Biosynthesis Enzyme Inhibitors as Promising Antimicrobial Drugs},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {3},
pages = {425},
doi = {10.3390/ph16030425}
}
EUVIMED